FTC and seven states seek contempt ruling against Shkreli over pharma ban
By Maya Yang
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions
https://www.theguardian.com/us-news/2026/oct/13/martin-shkreli-ftc-ruling-pharma-ban
#MartinShkreli #Pharmaceuticalsindustry #USjusticesystem #USnews #Contemptofcourt #Business #Law #TheGuardian #MayaYang